Benzodiazepines (Oral, Nasal, Rectal) - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

Refer to the Sedative/Hypnotics criteria for sedative and hypnotic benzodiazepines.

• Revision history
  • April 26, 2024
  • April 22, 2022
  • March 2020
  • March 2018
  • May 2017
  • Dec. 2014
  • March 2013
  • June 2011
  • Jan. 2009
  • April 2003
  • Dec. 2001
  • Dec. 2000
  • Dec. 1999
  • Nov. 1998
  • Nov. 1997
  • Dec. 1996.
  • Oct. 1993 (initially developed)